The accelerating pace of biotechnology is driving significant advancements in precision medicine. We are now witnessing the power of cancer biomarkers in patient stratification, the potential of miRNA in early cancer detection, and the efficacy of biomarker-guided targeted therapies, all contributing to more personalised and effective cancer treatment. Recognising the importance of public understanding and knowledge sharing, #Mirxes engages with the community regularly. Last week, our VP of Genomics, Zhao Pan, had an engaging sharing session with Singapore Chinese Chamber of Commerce & Industry members from diverse backgrounds. The session was a testament to the community's keen interest on this topic, with participants posing thoughtful questions. Pan also found the session rewarding, appreciating the breadth of perspectives exchanged. Through our engagement efforts, we hope early detection and effective management, facilitated by technological advancements, can significantly reduce the fear associated with a cancer diagnosis in our community. #detectwithmirxes #preventivehealthcare #earlydetection #healthcare #cancer #healthscreening #precisionmedicine #RNA #miRNA #earlydetectionsaveslives
